A trial to assess whether the pericyte coverage was a predictor for bevacizumab effectiveness in metastatic colorectal cancer (mCRC).
Latest Information Update: 20 Jul 2016
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 20 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology